People · Operator
Named in public records as an officer, director or promoter · active 2011–2025 · Biotechnology, Media & Content, Other Technology, Investment Vehicle, Other Health Care, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Fate Therapeutics Inc | — | Biotechnology | Series C | $241.3M | $2.0B | 2015 |
| COTA Racing & Entertainment LLC | — | Media & Content | Series C | $193.0M | $265.4M | 2011 |
| Proscia Inc. | — | Other Technology | Series B | $113.9M | $206.4M | 2025 |
| Mindstrong, Inc. | — | Other Technology | Series B | $52.0M | $944.1M | 2018 |
| COTA Emerald City Fund LP | — | Investment Vehicle | Series C | $46.5M | $426.0M | 2023 |
| Medmo, Inc. | — | Other Health Care | Series A | $31.7M | $44.7M | 2025 |
| 2100 Freedom, Inc. | — | Other | Series B | $17.7M | $294.7M | 2013 |
| Rollzi LLC | — | Other | Seed | $2.0M | $16.8M | 2022 |
Robert Epstein at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Robert Epstein on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Kurt Rechner | 2 | 3 |
| Harry Zimmerman | 2 | 3 |
| Alyssa Epstein | 2 | 2 |
| Robert Nelsen | 1 | 22 |
| Hemant Taneja | 1 | 21 |
| Bryan Roberts | 1 | 18 |
| Michael Lee | 1 | 15 |
| Amir Nashat | 1 | 14 |
| Christopher Thompson | 1 | 8 |
| Carl Weissman | 1 | 8 |
| Andrew Sturner | 1 | 7 |
| Richard Klausner | 1 | 7 |
| Bryan E. Roberts | 1 | 6 |
| Christopher Kelly | 1 | 6 |
| David Epstein | 1 | 5 |
| PAUL Grayson | 1 | 5 |
| Robert T. Nelsen | 1 | 5 |
| John Mendlein | 1 | 4 |
| Rad Weaver | 1 | 4 |
| William Rastetter | 1 | 4 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.